Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02677974 · ClinicalTrials.gov registry record
On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study
A clinical trial of Thrombotic and Bleeding Events, sponsored by On-X Life Technologies.
- Active
- Registry status
- 510
- Enrollment target
- 20
- Study locations
NCT02677974 is a study of Thrombotic and Bleeding Events that is active but no longer recruiting, run by On-X Life Technologies. The registered enrollment target is 510 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT02677974, a study of Thrombotic and Bleeding Events, is active but no longer recruiting, sponsored by On-X Life Technologies.
- ACTIVE NOT RECRUITING
- Registry status
- 510 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the proposed study is to assess the occurrence of bleeding, valve-related thromboembolism and valve thrombosis with the On-X Aortic Prosthetic Heart Valve when targeted at an International Normalized Ratio (INR) level of 1.8 (1.5-2.0 range) during a 5-year follow-up period. The objective will be to compare adverse event rates for patients in subgroups as listed below targeted at 1.8 (range 1.5 to 2.0) per On-X instructions for use to rates from the previous IDE trial (G050208).
Conditions Studied
Interventions
- DEVICE On-X Aortic Heart Valve replacement
Study Locations (20)
Texas
- University of Texas Southwestern - Dallas
- University of Texas Health Science Center - Houston - Houston
- Baylor Scott & White - Plano - Plano
Ohio
- The Lindner Center at The Christ Hospital - Cincinnati
- Cleveland Clinic - Cleveland
Virginia
- Sentara Norfolk General Hospital - Norfolk
- Carilion Clinic - Roanoke
Washington
- Swedish Medical Center - Seattle
- MultiCare Health System - Tacoma
Other
- Blackpool Victoria Hospital - Blackpool
- Hull & East Yorkshire Hospitals - Hull
Arizona
- Arizona Cardiothoracic & Neurology - Tucson
Connecticut
- Hartford Hospital - Hartford
Indiana
- Franciscan St. Francis - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 2015-11-10 |
| Est. Completion | 2027-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02677974
The ClinicalTrials.gov registry entry for NCT02677974 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 510 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is On-X Life Technologies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thrombotic and Bleeding Events appearing as the primary indexed condition, and to 1 intervention - of which On-X Aortic Heart Valve replacement is the first listed.
NCT02677974 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Texas, Ohio, Virginia.
Frequently Asked Questions
What is clinical trial NCT02677974 about?
NCT02677974 is a clinical study titled "On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study". The purpose of the proposed study is to assess the occurrence of bleeding, valve-related thromboembolism and valve thrombosis with the On-X Aortic Prosthetic Heart Valve when targeted at an International Normalized Ratio (INR) level of 1.8 (1.5-2.0 range) during a 5-year follow-up period. The object...
What is the current status of trial NCT02677974?
This trial is currently active not recruiting. The enrollment target is 510 participants. The study started on 2015-11-10. Estimated completion is 2027-08.
What conditions does trial NCT02677974 study?
This clinical trial studies the following conditions: Thrombotic and Bleeding Events.
What interventions are being tested in trial NCT02677974?
The interventions under investigation include: On-X Aortic Heart Valve replacement (DEVICE).
Who is sponsoring clinical trial NCT02677974?
This trial is sponsored by On-X Life Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02677974 being conducted?
This trial has 20 study locations across Arizona, Connecticut, Indiana, Maine, North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.